RIBOMIC Announces Presentation of Masked Preliminary Interim Data from Phase 2 Trials of RBM-007 for Wet Age-Related Macular Degeneration at the Retina Society 2021 Meeting
Data show a consistent safety profile and potential BCVA benefit in wAMD patients with suboptimal…